Scott Braunstein
Director, Esperion Therapeutics.
Companies
- AtaiBeckley Inc.Board member Jun 8, 2026 to now1
- RAPT Therapeutics, Inc.Board member Jun 24, 2025 to now2
- Atai Beckley N.V.Board member Jun 4, 2024 to now3
- Caribou Biosciences, Inc.Board member Jul 22, 2021 to now4
- Marinus Pharmaceuticals (United States)Chief executive officer Dec 13, 2019 to Feb 11, 20255
- Marinus Pharmaceuticals (United States)Chair Feb 28, 2019 to Feb 11, 20256
- Trevena IncBoard member Oct 1, 2018 to Jun 17, 20247
- Marinus Pharmaceuticals (United States)Board member Sep 20, 2018 to Feb 7, 20228
- Constellation Pharmaceuticals (United States)Board member Feb 20, 2019 to Jul 19, 20219
- Proteon TherapeuticsBoard member Jan 13, 2020 to Jun 11, 202010
- ZIOPHARM OncologyBoard member Sep 20, 2018 to Jan 3, 202011
- Esperion TherapeuticsBoard member Jun 15, 2015 to May 31, 201912
- Pacira BioSciences, Inc.Chief operating officer Jan 5, 2018 to Jan 5, 201813
- Pacira BioSciences, Inc.SVP, Strategy & Corp. Dev. Jul 15, 2015 to Jun 16, 201714
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Marinus Pharmaceuticals (United States)0 shares15Feb 11, 2025
- RAPT Therapeutics, Inc.0 shares16Mar 3, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Mar 3, 2026U 4,956 shares of RAPT Therapeutics, Inc.16
- Jan 30, 2026Granted 4,956 shares of RAPT Therapeutics, Inc.17
- Feb 11, 2025Returned to company 179,536 shares at $0.55 of Marinus Pharmaceuticals (United States)15
- Feb 7, 2025Returned to company 125,064 shares at $0.55 of Marinus Pharmaceuticals (United States)15
- Aug 14, 2024Bought 5,933 shares at $1.10 of Marinus Pharmaceuticals (United States)15
- Aug 5, 2024Sold 12,145 shares at $1.13 of Marinus Pharmaceuticals (United States)18
- Jun 18, 2024Granted 37,300 shares of Marinus Pharmaceuticals (United States)19
- Mar 27, 2024Exercised options 50,000 shares at $4.28 of Marinus Pharmaceuticals (United States)20
- Feb 16, 2024Sold 11,850 shares at $9.94 of Marinus Pharmaceuticals (United States)21
- Jan 18, 2024Granted 74,600 shares of Marinus Pharmaceuticals (United States)22
- Aug 8, 2023Sold 30 shares at $8.94 of Marinus Pharmaceuticals (United States)23
- Aug 7, 2023Sold 6,413 shares at $9.55 of Marinus Pharmaceuticals (United States)23
- Jan 26, 2023Granted 80,000 shares of Marinus Pharmaceuticals (United States)24
- May 24, 2022Granted 19,305 shares of Marinus Pharmaceuticals (United States)25
- Feb 4, 2022Granted 42,900 shares of Marinus Pharmaceuticals (United States)26
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARAtaiBeckley Inc., Board member
- 2
- 3SEC EDGARAtai Beckley N.V., Board member
- 4
- 5
- 6
- 7SEC EDGARTrevena Inc, Board member
- 8
- 9
- 10SEC EDGARProteon Therapeutics, Board member
- 11SEC EDGARZIOPHARM Oncology, Board member
- 12SEC EDGAREsperion Therapeutics, Board member
- 13
- 14
- 15
- 16
- 17SEC EDGARForm 4 filed Feb 2, 2026
- 18SEC EDGARForm 4 filed Aug 7, 2024
- 19SEC EDGARForm 4 filed Jun 20, 2024
- 20SEC EDGARForm 4 filed Mar 27, 2024
- 21SEC EDGARForm 4 filed Feb 21, 2024
- 22SEC EDGARForm 4 filed Jan 19, 2024
- 23SEC EDGARForm 4 filed Aug 8, 2023
- 24SEC EDGARForm 4 filed Jan 30, 2023
- 25SEC EDGARForm 4 filed May 26, 2022
- 26SEC EDGARForm 4 filed Feb 7, 2022